References

  1. Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology. 2005; 236(2):441-450. PubMed | Google Scholar

  2. Abrams Hospira R, Goldstein M. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer. 1950; 3(1): 74-85. PubMed | Google Scholar

  3. Burke M. Multiple primary cancers. Am J Cancer. 1936; 27:316-25. PubMed | Google Scholar

  4. Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5suppl):e369S-e399S. PubMed | Google Scholar

  5. Uday Patel, Navin Ramachandran, James Halls, Aneeta Parthipun and Catherine Slide. Synchronous Renal Masses in Patients With a Nonrenal Malignancy: Incidence of Metastasis to the Kidney Versus Primary Renal Neoplasia and Differentiating Features on CT. American Journal of Roentgenology. 2011 Oct;197(4):W680-6. PubMed | Google Scholar

  6. Choyke PL, White EM, Zeman RK, et al. Renal metastases: clinicopathologic and radiologic correlation. Radiology. 1987 Feb;162(2):359-63. PubMed | Google Scholar

  7. Kaneta T, Hakamatsuka T, Yamada T, Takase K, Sato A, Higano S, et al. FDG PET in solitary metastatic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. Ann Nucl Med. 2006 Jan;20(1):79-82. PubMed | Google Scholar

  8. Sánchez-Ortiz RF, Madsen LT, Bermejo CE, et al. A renal mass in the setting of a nonrenal malignancy: when is a renal tumor biopsy appropriate? Cancer. 2004; 101(10):2195-2201. PubMed | Google Scholar

  9. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.Hum Pathol. 2010;41(1):20-25. PubMed | Google Scholar

  10. Russo P. Partial nephrectomy for renal cancer: part I. BJU Int. 2010; 105(9):1206-220. PubMed | Google Scholar

&